ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Prioritize Safety And Mitigate Risk In HPAPI Manufacturing

  As highly potent active pharmaceutical ingredients become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

• Platform Reduces Product Development Time And Cost By 30%

  Using innovative capsule-filling equipment and processing technology, and mini-tablet and drug-layered beadlet manufacturing, you can have an adaptable, easily modified formulation.

• Liposome Vs. Lipid Nanoparticle: What's The Difference?

  Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.

• Safeguarding Cell Therapy Cryopreservation: Primary Containers

  Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.

• Plan For Your Extractables And Leachables Studies To Meet Submission Timelines

  Demonstrating the compatibility of any material in contact with drug product throughout its lifecycle (manufacture, containment, and delivery) is a necessity for a regulatory submission.

• Implementing Medium And High-Volume Drug Handling And Packaging Programs

  Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.

• Simultaneous Spray Drying For Combination Dry Powder Inhaler Formulations

  Three combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

• Maintaining Drug Bioavailability And Masking Taste With Microencapsulation

  Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.

• Selecting A Strategic Partner For Your Combination Product

  It is imperative to choose an experienced partner that can ensure the highest quality products, minimize supply chain disruptions, and efficiently bring safe, effective drug products to patients.

• The Gateway Delivery To The Brain

  Nose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress.